KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 260 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $32,315,671 | +967.7% | 102,100 | +470.4% | 0.44% | +825.5% |
| Q3 2023 | $3,026,711 | -92.6% | 17,900 | -90.6% | 0.05% | -93.5% |
| Q2 2023 | $41,093,075 | +2.8% | 189,500 | -13.9% | 0.73% | -5.8% |
| Q1 2023 | $39,960,800 | +612.8% | 220,000 | +671.1% | 0.77% | +777.3% |
| Q4 2022 | $5,606,538 | -12.6% | 28,532 | 0.0% | 0.09% | -1.1% |
| Q3 2022 | $6,417,000 | +69.0% | 28,532 | -4.9% | 0.09% | +71.2% |
| Q2 2022 | $3,796,000 | +114.0% | 30,000 | +106.9% | 0.05% | +160.0% |
| Q3 2021 | $1,774,000 | +3.7% | 14,500 | -3.3% | 0.02% | -9.1% |
| Q2 2021 | $1,710,000 | – | 15,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,885,602 | $135,763,000 | 12.56% |
| PFM Health Sciences, LP | 499,510 | $35,965,000 | 2.95% |
| Eventide Asset Management | 901,077 | $64,878,000 | 2.10% |
| ACUTA CAPITAL PARTNERS, LLC | 56,000 | $4,032,000 | 1.95% |
| Logos Global Management LP | 69,658 | $5,015,000 | 1.91% |
| Vivo Capital, LLC | 223,692 | $16,106,000 | 1.46% |
| Atika Capital Management LLC | 90,000 | $6,480,000 | 1.24% |
| EAM Global Investors LLC | 27,126 | $1,953,000 | 1.14% |
| EAM Investors, LLC | 40,516 | $2,917,000 | 0.91% |
| MOODY ALDRICH PARTNERS LLC | 25,844 | $1,861,000 | 0.56% |